Latest News

Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.

This Canadian stock has a proven record of paying dividends and consistently raising their payouts in the years ahead.

Oracle's fiscal Q1 revenue grew nearly 30% with a record $23 billion cash flow and surging backlog, as analysts cite an AI monetization inflection point supporting a Moderate Buy consensus.

One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.

Don't put all of your eggs in one basket.

AMD's data center momentum clashes with Qualcomm's valuation discount, but customer concentration and geopolitical risks complicate both bets.

Broadcom's custom AI chips are becoming more popular with AI hyperscalers.

National Beverage stock has lots of problems right now, and no good solutions.

Eli Lilly is expanding into women's health, targeting endometriosis and pregnancy disorders by hiring experts and strategic investments.

TSMC reported August 2026 revenue up 53.3% year over year, with strong margins, insider buying, and analysts maintaining a consensus Buy rating and $523.22 average price target.

Copart acquires ACV, merging digital inspection with physical logistics amid volume declines.

One company is scaling revenue rapidly but burning cash; the other is pioneering gene therapy with minimal sales and massive losses.

Robotaxis could become a $10 trillion global industry.

AeroVironment shares are falling after B of A Securities maintained its Buy rating on the stock but cut its price target to $185 from $225.

Stanley Druckenmiller thinks cuts to Social Security are on the horizon.

Super Micro Computer (NASDAQ:SMCI) stock jumps 7% Friday as tech rallies. Explore key support, resistance, technical trends and Benzinga Edge scores.

Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.25% on an annualized basis producing an average annual return of 17.44%. Currently, Incyte has a market capitalization of $24.69 billion.

VFV feels like a complete portfolio, but it’s really a concentrated bet on U.S. large caps and the U.S. dollar.

Iran war and $100 oil drive large-cap outflows, but investors keep buying VOO, QQQ and semiconductor ETFs.

A customer needs a service nearby. What happens next?A few years ago, the answer was fairly predictable. They opened Google, typed something like “electric

SpaceX CFO Bret Johnsen says Flight 14 should be Starship’s first revenue-generating mission as traders give a September launch 87% odds.

But the crypto market bill needs substantial Democrat support.

NVIDIA (NVDA) targets 70% growth as CEO Jensen Huang forecasts up to $4T in AI spending. Read about NVDA’s partners and key constraints